FENOFIBRATE
- Product NDC
- 50090-6973
- Requested package NDC
- 50090-6973-1
- 11-digit product format
- 500906973
- Labeler code
- 50090
- Product ID
- 50090-6973_de8ee364-daeb-4826-a135-e06db47424f5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FENOFIBRATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076509
- Marketing category
- ANDA
- Marketing start
- 2022-06-22
- Substance
- FENOFIBRATE
- Active strength
- 160 mg/1
- Pharmacologic classes
- Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076509-001 | FENOFIBRATE | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | |
| A076509-002 | FENOFIBRATE | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076509-001 | AB |
| A076509-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A076509-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2008-03-26 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A076509-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | RS | 2008-03-26 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A076509-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076509-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076509-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076509-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A076509-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076509-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076509-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076509-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076509-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076509-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076509-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076509-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076509-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076509-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076509-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076509-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076509-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076509-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A076509-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A076509-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076509-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076509-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076509-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076509-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076509-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076509-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A076509-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A076509-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076509-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076509-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A076509-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A076509-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A076509-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A076509-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A076509-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076509-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A076509-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A076509-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A076509-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A076509-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FENOFIBRATE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FENOFIBRATE | 160 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U202363UOS | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 349287 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3f2b3a16-7735-487e-9a2c-e078a18df1bc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 193bb7da-5c03-8f95-9048-23ef403846b0 | Product name | 3 | 20250616 |
| fa35fb9a-7146-716b-13c8-bc1f60030232 | Product name | 9 | 20250114 |
| cfc78bfa-7d55-47e5-aeb7-71cd79f5ca07 | Product name | 8 | 20231212 |
| 53d5b6b7-785a-4500-9460-263c7f8424b8 | Product name | 5 | 20210105 |
| ed9d55d4-85bd-0ee7-5b4a-b705646a3a66 | Product name | 9 | 20200708 |
| 36a239c8-03fb-0083-81af-6c1afb195671 | Product name | 1 | 20140508 |
| a0296d70-ca85-018c-84e8-cf3f630976b7 | Product name | 1 | 20140508 |
| f2e3e9c8-a2f9-0cc3-a5a5-6dfd0279372a | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6973-0 | FENOFIBRATE | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 50090-6973-1 | FENOFIBRATE | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6973-0 | EA - Each | 50090-6973 | df3f8496-44ac-4848-9ab4-a93cf85ac4b1 | 1 | 2024-02-14 |
| 50090-6973-1 | EA - Each | 50090-6973 | 944fbcaf-9ae5-4ce3-806f-25c1ca6b0d17 | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6973 | FENOFIBRATE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 2 package rows | 20240102_3f2b3a16-7735-487e-9a2c-e078a18df1bc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FENOFIBRATE | FENOFIBRATE | Amneal Pharmaceuticals LLC | 65f5dcad-5073-4347-9ec9-e7f350b134c4 | 2026-06-06 | Warnings, Adverse reactions | 076509 ANDA076509 |
| FENOFIBRATE | FENOFIBRATE | Northwind Health Company, LLC | 4b4447a1-8136-4258-b2c8-c5f9c1bcec92 | 2025-12-26 | Warnings, Adverse reactions | 076509 ANDA076509 |
| FENOFIBRATE | FENOFIBRATE | AvPAK | d4e1d692-3c03-7406-ee06-7a6fb39ed3e7 | 2025-11-16 | Warnings, Adverse reactions | 076509 ANDA076509 |
| FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | 882ee82a-3c56-4173-af42-68c3aadc8aa7 | 2025-10-02 | Warnings, Adverse reactions | 076509 ANDA076509 |
| FENOFIBRATE | FENOFIBRATE | PD-Rx Pharmaceuticals, Inc. | 35ba17d9-0dd7-4f15-8f74-be5fd15f1917 | 2025-04-08 | Warnings, Adverse reactions | 076509 ANDA076509 |
| FENOFIBRATE | FENOFIBRATE | A-S Medication Solutions | 3f2b3a16-7735-487e-9a2c-e078a18df1bc | 2024-01-01 | Warnings, Adverse reactions | 076509 ANDA076509 50090-6973-1 50090-6973 50090697301 |
| FENOFIBRATE | FENOFIBRATE | A-S Medication Solutions | f937a176-3d3e-4dc6-a7d4-c1a4749c7a7f | 2023-12-27 | Warnings, Adverse reactions | 076509 ANDA076509 |
| FENOFIBRATE | FENOFIBRATE | Amneal Pharmaceuticals of New York LLC | fa08cf6a-d306-4979-9b23-ac7febf4fd12 | 2021-04-01 | Warnings, Adverse reactions | 076509 ANDA076509 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349287 | fenofibrate 160 MG Oral Tablet | PSN | 3f2b3a16-7735-487e-9a2c-e078a18df1bc | 3 |
| 349287 | fenofibrate 160 MG Oral Tablet | SCD | 3f2b3a16-7735-487e-9a2c-e078a18df1bc | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-6973-1 | 50090697301 | 90 TABLET in 1 BOTTLE (50090-6973-1) | 90 tablet | 2023-12-21 | No | No | Current |